Share your thoughts, experiences and ideas which could help others.
Please, no commercial content and no spam.
Make sure you enter your email address correctly so we can let you know when it goes live after a short moderation process.
Lenalidomide , initially known as CC-5013 and marketed as Revlimid by Celgene, is a Derivative (chemistry) of thalidomide introduced in 2004.It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted t...
Read more on Wikipedia